Browse by category

WL Gore & Associates (Gore) has announced that GORE SYNECOR Preperitoneal Biomaterial is now available in Europe, Middle East and South...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Fractyl Health has announced positive early data from the open-label REVEAL-1 cohort of its ongoing REMAIN-1 pivotal study. The results...

ENDRA Life Sciences has revealed a new strategic direction to develop and deploy its Thermo-Acoustic Enhanced UltraSound system (TAEUS)...

Tirzepatide improves kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection...

Outcomes from the By-Band-Sleeve trial has confirmed the safety and effectiveness of bariatric and metabolic surgery (BMS) and that...

e full results from the SOUL cardiovascular outcomes trial, investigating the effects of Rybelsus (semaglutide) tablets 14 mg on reducing...

Analysis of the SCORE and PRIDE studies shows semaglutide results in improved functional outcomes, health-related quality of life and CV...

A USC Schaeffer Center white paper entitled, ‘Lifetime Social Returns From Expanding Access to Anti-Obesity Medication’, finds expanded...

The first patient has been dosed in Corbus Pharmaceuticals in the single ascending dose/multiple ascending dose (SAD/MAD) portion of the...